Dow Jones Newswires: Takeda trial for Crohn’s Perianal Fistulas treatment misses primary endpoint
Takeda said Tuesday its trial of darvadstrocel in the treatment of complex Crohn’s Perianal Fistulas didn’t meet its primary endpoint based on topline data.